insights_auto
Why is 4DX down 3.62%?
Dive Deeperchevron_right
4DX:ASX
4DMedical Ltd
A$3.73
arrow_downward
-3.62%(-0.14) 1D
Oct 20, 4:10:25 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4DX...
Open
A$3.87
High
A$3.92
Low
A$3.71
Mkt. cap
2.25B
Avg. vol.
3.81M
Volume
2.38M
52-wk high
A$7.55
52-wk low
A$1.40
EPS
-A$0.38
Shares outstanding
602.24M
No. of employees
181
Open
A$3.87
High
A$3.92
Low
A$3.71
Mkt. cap
2.25B
Avg. vol.
3.81M
Volume
2.38M
52-wk high
A$7.55
52-wk low
A$1.40
EPS
-A$0.38
Shares outstanding
602.24M
No. of employees
181
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Top 3 Australian Growth Stocks To Watch In October 2026
ad-hoc-news.de
·
2 days ago
Three analysts set AUD 4.37 target for 4Dmedical stock
Profile
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
About 4DMedical Ltd